FDA Structured Product Label
Zubrin™ Rapidly-Disintegrating Tablets
Rendered from Roxee's cached FDA SPL package contents for on-page reading. Use Open original for the raw FDA ZIP/XML source.
- Sponsor
- Intervet, Inc.
- NADA
- 141-193
- Status
- RX
- Form
- Tablet
- Route
- Oral
- Species
- Dog, No Use Class Stated Or Implied
Composition / specifications
Each rapidly- disintegrating tablet contains 30, 50, 100, or 200 mg tepoxalin.
Dogs
Indication
For the control of pain and inflammation associated with osteoarthritis in dogs.
Dosage
Administer 10 mg/kg (4.5 mg/lb) or 20 mg/kg (9.1 mg/lb) on the initial day of treatment, followed by a daily maintenance dose of 10 mg/kg. Due to observed variability in tepoxalin metabolism, a higher initial dose of 20 mg/kg may be given to increase the likelihood that plasma active metabolite levels will reach a minimum effective concentration following the first oral administration.
The duration of treatment at 10 mg/kg should be based on clinical response and patient tolerance of drug treatment.
Limitations
Federal law restricts this drug to use by or on the order of a licensed veterinarian.